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ABSTRACT
Transcriptional Regulatory Networks (TRNs) coordi-
nate multiple transcription factors (TFs) in concert to
maintain tissue homeostasis and cellular function.
The re-establishment of target cell TRNs has been
previously implicated in direct trans-differentiation
studies where the newly introduced TFs switch on
a set of key regulatory factors to induce de novo
expression and function. However, the extent to
which TRNs in starting cell types, such as dermal
fibroblasts, protect cells from undergoing cellular
reprogramming remains largely unexplored. In or-
der to identify TFs specific to maintaining the fi-
broblast state, we performed systematic knockdown
of 18 fibroblast-enriched TFs and analyzed differen-
tial mRNA expression against the same 18 genes,
building a Matrix-RNAi. The resulting expression ma-
trix revealed seven highly interconnected TFs. Inter-
estingly, suppressing four out of seven TFs gener-
ated lipid droplets and induced PPARG and CEBPA
expression in the presence of adipocyte-inducing
medium only, while negative control knockdown cells
maintained fibroblastic character in the same induc-
tion regime. Global gene expression analyses further
revealed that the knockdown-induced adipocytes ex-
pressed genes associated with lipid metabolism and
significantly suppressed fibroblast genes. Overall,
this study reveals the critical role of the TRN in pro-
tecting cells against aberrant reprogramming, and
demonstrates the vulnerability of donor cell’s TRNs,
offering a novel strategy to induce transgene-free
trans-differentiations.
INTRODUCTION
In any given cell, a set of transcription factors (TFs) is ex-
pressed and works in concert to govern cellular homeosta-
sis and function (1). The Transcriptional Regulatory Net-
works (TRNs) in somatic cells are believed to be robust and
act to prevent cells from aberrant plasticity (2). However,
recent works have revealed that somatic cells in mammals
are more plastic than previously thought (3). Particularly,
Takahashi andYamanaka demonstrated this notion by gen-
erating embryonic stem-like cells (or iPSC) from dermal fi-
broblasts after ectopic expression of Oct4, Sox2, Klf4 and
cMyc (4,5). Additionally, increasing numbers of direct cell
reprogramming, or trans-differentiations, toward neurons,
hepatocytes and cardiomyocytes have also been reported
(6–9).
Efficient trans-differentiations are believed to reset the
TRN of the original cell type and re-establish the target
TRN with a defined set of TFs (10–12). Although numer-
ous examples have shown successful induction of target
cell-specific functions and expression, most have largely ig-
nored the involvement of the starting cell type, generally
dermal fibroblasts. Several recent examples of (direct) cell
reprogramming reported that a large number of fibroblast-
specific genes and epigenetic marks remained intact even
after inducing cell reprogramming (10–13). These reports
suggest that the fibroblast TRN is highly robust and it may
act to safeguard the cells from undergoing cell conversions.
Therefore, how much the fibroblast-specific network plays
a role in ‘inhibiting’ cell reprogramming remains to be elu-
cidated.
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To this aim, we first identified 18 fibroblast-enriched
TFs based on the compendium of 988 human primary
cells and tissues (FANTOM5) (14) and inferred a fibrob-
last TRN based on the Matrix-RNAi method (15–17).
The analysis revealed inter-TF relationships including tran-
scriptional activation/repression, directionality and com-
binatorial regulation of defined TFs and showed that 7
out of the 18 TFs were highly interconnected and in-
fluenced the majority of the fibroblast network. We fur-
ther demonstrate that by targeting four out of seven ma-
jor TFs, we could induce adipocyte-like cells in the pres-
ence of adipocyte medium without any ectopic expression
of TFs. The global expression analysis revealed significant
upregulation of adipocyte-specific marker genes and sup-
pression of fibroblast-enriched genes. This study demon-
strates the important inhibitory role of fibroblast-specific
TFs in maintaining the fibroblast state and that the dis-
ruption of the underlying TRN can greatly enhance direct
trans-differentiations. This work is part of the FANTOM5
project. Data downloads, genomic tools and co-published
manuscripts are summarized at http://fantom.gsc.riken.jp/
5/.
MATERIALS AND METHODS
Fibroblast-enriched TFs selection
Out of 988 CAGE human sample dataset (FANTOM5), 41
libraries are classified as fibroblasts from various tissues.
To select fibroblast-enriched TFs from FANTOM5 dataset,
the mean expression ratio of fibroblast was compared to
the mean expression value of all non-fibroblast TFs in the
dataset. All promoters with zero tag counts were set to 0.1.
TFs for which expression ratio (fold-change) was above 1.5
were selected as candidates for fibroblast-enriched TFs. The
human Illumina microarray dataset contained 14 human
cell types: NB1RGB fibroblast, mammary epithelial cells
(HMEC), keratinocytes (KER), renal epithelial cell (HRE),
normal articular chondrocytes derived from the healthy
knee joint (NHAC), prostate epithelial cells (PREC), os-
teocytes (OST), mesenchymal stem cell (MSC), skeletal
muscle cells (SMC),MSC-ADP (MSC-derived adipocytes),
CD14+ primary monocytes (MON), small airway epithe-
lial cells (SAEC) and induced pluripotent stem (iPS) cells
derived from NB1RGB. To select fibroblast-enriched TFs,
NB1RGB fibroblast expression data were compared with
the data of other 13 cell types one by one to calculate
the expression ratio. TFs for which the average expression
ratio in fibroblast was >1.5 were selected as candidates
of fibroblast-enriched TFs. The intersect of TFs from the
FANTOM5 data and Illumina microarray data was chosen
as fibroblast-enriched TFs.
Cell culture
NB1RGB, normal human neonatal skin fibroblast cells,
and NHDF-Adult, normal human adult skin fibroblasts,
were obtained from RIKEN Bioresource Center (Tsukuba,
Japan) and Lonza (#CC-2511, Lonza, USA), respectively,
and cultured in Minimum Essential Medium alpha (Wako,
Japan) supplemented with 10% fetal bovine serum and
penicillin/streptomycin (100 U/ml and 100 g/ml; Invitro-
gen, USA) at 37◦C in a 5% CO2. MSCs (#PT-2501, Lonza,
USA) and pre-adipocytes (#PT-5020, Lonza, USA) were
cultured and differentiated in accordance with manufac-
turer’s instructions. See section ‘Adipogenic induction’ for
details.
siRNA transfection and RNA extraction
Fibroblast cells were seeded in 12-well cell culture plate
(Nunc) at a density of 2 × 104 cells/well one day before
forward transfection was performed with 50 nM (final con-
centration) of each stealth small interfering RNA (siRNA),
2.5l of Lipofectamine RNAiMAX (Invitrogen, USA) and
Opti-MEM (Invitrogen, USA) according to the manufac-
turer’s instructions. Two or more stealth siRNAs (Invitro-
gen, Carlsbad, CA, USA) were tested for each target gene,
and the one giving the highest level of knockdown was used
for the Matrix-RNAi analysis. siRNA sequences are listed
in Supplementary Table S4. Stealth RNAi negative univer-
sal control MED (Invitrogen) was used to calibrate siRNA
transfection.
RNAs were extracted with RNeasy mini kit (QIAGEN,
Germany) according to the manufacturer’s instructions.
RNA was quantified with NanoDrop (NanoDrop Tech-
nologies, USA). All siRNA transfection experiments were
performed in biological quadruplicate.
Quantitative real-time RT-PCR and Matrix-RNAi Analysis
Reverse transcription reaction was performed with Prime-
Script RT-PCR Kit (Perfect Real Time, TAKARA BIO)
and GeneAmp PCR System 9700 (Applied Biosystems,
USA) according to the manufacturer’s instructions. Quan-
titative real-time RT-PCR (qRT-PCR) was performed in 10
l reaction mixture with SYBR Premix Ex TaqTM (Perfect
Real Time, TAKARABIO) on anABI 7900FastReal-Time
PCR System (Applied Biosystems, USA). PCR parameters
consisted of heating at 95◦C for 10 s, followed by 40 cycles
at 95◦C for 5 s and at 60◦C for 30 s. The relative amount
(expression ratio) of the target gene mRNA was normal-
ized to the endogenous GAPDH mRNA using the 2−CT
methods. Standard deviation (SD) and P-value of CT
in a total of four biological replicates were calculated us-
ing a threshold to select significant transcriptional regula-
tion edges. The cutoff threshold value was arbitrarily de-
fined as 3 SD above the mean and P-value< 0.05. Only sig-
nificant perturbations that passed the threshold value were
used as reliable transcriptional regulation edges for depict-
ing the Matrix-RNAi network. The networks were drawn
using Cytoscape. The primer information is summarized in
Supplementary Table S4.
Adipogenic induction
Two days post siRNA transfection, culture medium was
replaced with supplemented MEM alpha. One day later,
transfected cells andMSCs were treated with adipogenic in-
duction medium for three days (IBMX, indomethacin, dex-
amethasone, insulin; Lonza, PT-3102B/PT-4135) followed
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by maintenance medium for 4 days (insulin; Lonza, PT-
3102A). The adipocyte induction regime was repeated for
one more cycle (total two cycles).
Lipid staining and quantification
Knockdown-induced adipocytes (KD-iADP) were gener-
ated in 12-well or 24-well plates. Two weeks post adipogenic
induction, cells were rinsed with phosphate buffered saline
(PBS) and fixed with 4% paraformaldehyde (Merck) in
PBS. Lipid droplets and nucleus were stained with LipidTox
(Invitrogen) and Hoechst 33342 (Invitrogen), respectively.
Stained lipid droplets and nucleus were quantified using the
Cellomics ArrayScan Reader XTi (Thermo Scientific). The
experiment was repeated three times to assess reproducibil-
ity.
Microarray analysis
First- and second-strand cDNA and cRNAs from 500 ng
of total RNA were prepared using the Illumina TotalPrep
RNA Amplification Kit (Ambion, USA). The concentra-
tion of cRNA was measured with NanoDrop (NanoDrop
Technologies, USA) and the size distribution of cRNA was
evaluated using theAgilent 2100Bioanalyzer (Agilent Tech-
nologies, USA). For gene expression profiling, 500 ng of
cRNA was employed for labeling and hybridization using
HumanWG-6 v3 Expression BeadChip kit or HumanHT-
12 v4 Expression BeadChip Kit according to the manufac-
turer’s instructions. All microarray analysis was performed
in biological triplicate. The Illuminamicroarray dataset was
registered at Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/) atNCBI as accession numberGSE44439.
RESULTS
Selection of fibroblast-enriched TFs
Transcription Regulatory Networks (TRNs) are composed
of constitutive and cell-specific sub-networks to coordinate
biological functions andmaintain cellular phenotype (1). In
order to infer gene regulatory interactions in fibroblast cells
we first identified fibroblast-enriched TFs based on the gene
expression data produced by the FANTOM5 consortium
(Functional Annotation Of the Mammalian Genome 5), in
which 41 out of 988 samples were classified as fibroblasts
from various tissues (14,18). The enrichment score for each
TF was calculated based on the mean expression of a TF
across 41 types of fibroblasts divided by the mean expres-
sion across 947 non-fibroblast samples. Fifty TFs showing
a fold-change >1.5 and a P-value less than 0.05 were iden-
tified as the first set of fibroblast-enriched TFs (Supplemen-
tary Table S1). SinceNB1RGB, a primary fibroblast cell line
previously used for cell reprogramming (10–12), was miss-
ing from the FANTOM5 data, we used a similar strategy to
select 44 fibroblast-enriched TFs that exhibited an enrich-
ment score>1.5 (P-value< 0.05) betweenNB1RGB and 13
non-fibroblastic primary cell types based on ourmicroarray
expression (Supplementary Table S2). Eighteen TFs, which
overlapped between the FANTOM5 selection and the mi-
croarray selection, were chosen for further analyses (Table
1).
Building a fibroblastic TRN model by Matrix-RNAi
In order to investigate the gene regulatory relationships
among the 18 fibroblast-enriched TFs, we carried out the
Matrix-RNAi perturbation analysis where each selected TF
was systematically perturbed using siRNA. Subsequently,
differential gene expressions of all 18 TFs were measured by
means of quantitative RT-PCR (15,16), resulting in an 18-
by-18 expression matrix (Supplementary Table S3). Based
on the expression analysis, 72 regulatory edges were con-
sidered significant (P-value < 0.05 using Student’s t-test).
Fifty-three edges were activating and 19 were inhibiting
(Figure 1A). The ratio of activating-to-inhibiting edges was
similar to that of previously reported Matrix-RNAi in hu-
man hepatoma cell line, HepG2, and human monoblastic
cell line, THP-1 (15,16).
TRNs are known to have hierarchical topology in dis-
crete layers (19,20). In order to identify TFs with the most
regulatory influence in the fibroblast network, the num-
bers of upstream and downstream target genes were quan-
tified for each of the 18 TFs (Figure 1B). An influential-
set, which consists of PRRX1, OSR1, FOXD1, HOXC4,
LHX9, TBX3 and TWIST2, targeted five or more TFs in
the fibroblast TRN. This influential-set explained 62.5% of
the total number of regulatory edges and they collectively
targeted 15 out of 18 TFs represented in the network. Upon
a closer examination of the fibroblastic network, the inter-
actions among OSR1–PRRX1–TWIST2 were notably co-
ordinated, regulating one another in both directions, pos-
sibly working in concert to modulate downstream genes in
fibroblasts (Figure 1C). Furthermore, the top two TFs with
the highest number of target genes, PRRX1 and OSR1, col-
lectively targeted all TFs in the influential-set, and covered
13 out of 18 TFs in the fibroblast network (Figure 1D). Ret-
rospectively, six out of seven influential TFs were ranked
among top 20 in the FANTOM5 list, while the seven TFs
were evenly distributed in the microarray list (Supplemen-
tary Tables S1 and S2). This seems to suggest that the rich
coverage of multiple cell types in the FANTOM5 dataset
leads to a more informative set of TFs relevant to the main-
tenance of fibroblast network.
Combinatorial TF-knockdown destabilizes fibroblast net-
work and assists trans-differentiation toward adipocyte
Because multiple TFs mutually coordinate their activity
to implement biological function and to maintain home-
ostasis (1), we reasoned that the combinatorial knockdown
of a defined set of TFs might efficiently disrupt the fi-
broblastic TRN and broadly downregulate fibroblast genes.
Such combinatorial knockdown would further decrease
the stability of the fibroblast network where a chemical
cocktail may provoke trans-differentiation into neighbor-
ing cell types. Since the protocols for adipogenic differenti-
ation from MSCs and pre-adipocytes have been well estab-
lished (21–23), we investigated the fibroblast-to-adipocyte
transition after suppressing the fibroblastic network fol-
lowed by repeated inductions of IBMX, dexamethasone, in-
domethacin and insulin, hereby referred to as adipogenic-
induction medium (Figure 2A).
Adipogenesis is accompanied by a clear change in mor-
phology along with the formation of lipid droplets, which
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Table 1. List of 18 fibroblast-enriched transcription factors based on FANTOM5 and microarray gene expression profiles
No. Gene ID Gene name Symbol
Enrichment score
(FANTOM 5)
Enrichment score
(Microarray)
1 13345 Twist basic
helix-loop-helix
transcription factor 2
TWIST2 3.60 3.78
2 56956 LIM homeobox 9 LHX9 3.57 1.87
3 283078 Mohawk homeobox MKX 3.23 2.79
4 5396 Paired related
homeobox 1
PRRX1 3.00 3.08
5 51450 Paired related
homeobox 2
PRRX2 2.67 3.66
6 4487 Msh homeobox 1 MSX1 2.52 2.62
7 7291 Twist basic
helix-loop-helix
transcription factor 1
TWIST1 2.51 1.98
8 130497 Odd-skipped related
1 (Drosophila)
OSR1 2.34 1.56
9 10370 Cbp/p300-interacting
transactivator, with
Glu/Asp-rich
carboxy-terminal
domain, 2
CITED2 2.30 2.90
10 862 Runt-related
transcription factor
1; translocated to 1
(cyclin D-related)
RUNX1T1 2.23 2.00
11 297 Forkhead box D1 FOXD1 1.95 3.62
12 6926 T-box 3 TBX3 1.93 1.71
13 4784 Nuclear factor I/X
(CCAAT-binding
transcription factor)
NFIX 1.87 1.89
14 3215 Homeobox B5 HOXB5 1.64 2.39
15 3224 Homeobox C8 HOXC8 1.64 4.21
16 4212 Meis homeobox 2 MEIS2 1.63 2.26
17 3223 Homeobox C6 HOXC6 1.51 3.49
18 3221 Homeobox C4 HOXC4 1.51 2.20
can be observed under the standard phase-contrast micro-
scope without additional preparation. In case of MSCs,
a progenitor of adipocytes, the cells can efficiently differ-
entiate into adipocytes possessing lipid droplets after 10
days of adipogenic induction medium (MSC-ADP; Fig-
ure 2B). In case of scramble siRNA transfected fibroblasts,
no lipid formation was observed even when the cells were
continuously stimulated with the same adipogenic medium
(Figure 2B). Thereafter, we sought to test whether sup-
pression of fibroblast network by means of siRNA knock-
down can promote adipogenesis. All aforementioned 18
TFs were individually knocked down using siRNA followed
by adipogenic-induction medium. After one week, we read-
ily observed lipid droplet accumulations only when OSR1,
PRRX1, LHX9 or TWIST2 was depleted (Figure 2B) but
very few or no adipocytes were observed for the other 14
TFs (Supplementary Figure S1). Because TFs often work
in concert to maintain TRN, we combined PRRX1 and
OSR1 (2-mix) and PRRX1, OSR1, LHX9 and TWIST2
(4-mix) and transfected fibroblasts followed by adipogenic-
induction medium. Remarkably, when we quantified the
number of accumulated lipids based on fluorescent label-
ing (Figure 2C), we observed a significant increase in the
number of lipid droplets in the 4-mix combination when
compared to individual knockdowns (Figure 2D). Further-
more, when the 2-mix and 4-mix combinations were ec-
topically expressed in MSCs, the formation of adipocytes
was significantly reduced when compared to the vector con-
trol (Supplementary Figure S2). These loss-of-function and
gain-of-function analyses strongly suggest that the fibrob-
lastic network plays an important role in ‘locking’ the cells
in their native state, protecting the cells from aberrant trans-
formations. To avoid any batch effects, we could also in-
duce lipid droplet accumulation in dermal fibroblasts de-
rived from a different individual (normal human dermal
fibroblasts––adult; Supplementary Figure S3).
Gene expression profile of adipocyte-like cells
To further characterize the 4-mix KD-iADP, we per-
formed genome-wide transcription profiling to explore
the global gene expression patterns of TF-suppressed fi-
broblasts with/without adipogenic-induced medium. The
number of differentially regulated genes was significantly
larger in KD-iADP cells when compared to cells with the
suppressed fibroblast network without adipogenic induc-
tion (KD-FIB) and control fibroblast cells treated only
with adipogenic-induction medium (NC-iADP) (adjusted
P-value < 0.05; Figure 3A). Furthermore, several key
adipocyte genes, such as PPARG, LEPR and FABP4, were
significantly upregulated only in KD-iADP after 2 weeks
of cultivation (Figure 3B). Gene ontology analysis further
revealed that the combination of network suppression and
adipogenic induction enhanced genes involved in lipid, fatty
acid, coenzyme, and steroid metabolic processes, while the
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Figure 1. Establishment of fibroblastic transcriptional regulatory network (TRN) by means of Matrix-RNAi. (A) To reconstruct the fibroblastic TRN,
edges with differential expression greater or less than 1.5 log-2 ratio (P-value < 0.05) were selected. Seven nodes with the highest regulatory edges were
identified as influential TFs (blue nodes) and the remaining TFs were considered minor nodes (orange). Blue and red edges represent activating and
inhibiting regulations, respectively. The thickness of the edges represents the strength of regulation based on the differential gene expression. (B) Scatter
plot revealing the numbers of downstream (output) and upstream (input) target genes (four or less target genes in red; five or six target genes in orange;
seven or more target genes in purple). (C) A selection of the seven major TFs demonstrating the dense interconnectivities. (D) The first neighboring nodes
for the two TFs with the highest number of target genes, PRRX1 and OSR1, covering 11 out of 18 TFs. The sizes of the nodes indicate the number of
edges per node.
other conditions led to few or none of adipocyte-related
genes (Figure 3C). Interestingly, KD-iADP cells also down-
regulated a large proportion of fibroblast genes such as
TGFB2, COL5A1, FAP and MMP10 where the genes as-
sociated with developmental processes and muscle organ
development were significantly suppressed (Supplementary
Figure S4).
Genome-wide expression comparison of knockdown-induced
adipocytes to bona fide adipocytes
In order to further understand the transition of KD-iADP
cells relative to other sources of adipocytes, we addition-
ally performed genome-wide transcriptional profiling in-
cluding pre-adipocytes and MSCs. The principal compo-
nent analysis (PCA) revealed that KD-iADP positioned in
line with the pre-adipocyte differentiation pathway rather
than the MSC differentiation pathway after 2 weeks (Fig-
ure 4A). These results suggest that KD-iADP may be an
intermediate of pre- and mature adipocytes, indicating that
a prolonged cultivation of these cells may induce a more
mature form of adipocytes. In order to further assess the
degree of trans-differentiation, we analyzed the number of
differentially regulated genes for network-suppressed cells
(KD-FIB), adipogenic-induced cells (NC-iADP), and both
network-suppressed and adipogenic-induced (KD-iADP)
cells, and compared them to genes which were highly ex-
pressed in either pre-adipocytes, mature adipocytes, or
MSC and MSC-derived adipocytes when compared to fi-
broblasts (Figure 4B). Notably, KD-iADP cells induced
more than 55% of genes expressed in mature adipocytes as
well as in MSC-derived adipocytes, while a smaller portion
of the induced genes overlapped with the pre-adipocytes
and MSCs. It is important to note that the knockdown and
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Figure 2. TF-knockdown promotes trans-differentiation from fibroblast to adipocyte. (A) Experimental workflow to generate adipocyte-like cells from
fibroblasts bymeans of siRNA transfection followed by two cycles of adipogenic ‘induction’ medium and ‘maintenance’ medium. (B) Fibroblast cells trans-
fected with scramble siRNA failed to generate lipid droplets while mesenchymal stem cells (MSCs) generated lipid droplets in the presence of adipogenic-
induction medium. Knockdown of OSR1, PRRX1, LHX9 and TWIST2 induced adipocyte-like cells characterized by lipid accumulation. (C) For the
quantification of lipids, cells were stained with LipidTox (red) and Hoescht (nucleus; blue). (D) The quantification of fluorescently labeled lipid droplets
for single TF and combinatorial knockdown using the Cellomics ArrayScan image analysis software. 2-mix (OSR1 and PRRX1); 4-mix (LHX9, OSR1,
PRRX1 and TWIST2). * denotes that 4-mix knockdown was statistically significant compared to individual TF transfections (Student’s t-test P-value <
0.05). Scale bars = 50 m.
the induction medium alone failed to prompt adipocyte-
associated genes in fibroblasts, and that no significant
MSC genes were induced, suggesting that the transition is
a direct process. However, adipogenic-induction medium
alone could lead to a significant downregulation of fibrob-
last genes when compared to pre-adipocytes, where the
combined knockdown and the induction medium led to
a slightly more downregulation of fibroblast genes (Fig-
ure 4C).
DISCUSSION
In this study, we identified 18 fibroblast-enriched TFs based
on the large collection of human gene expression database
(FANTOM5) and inferred the TRN of human dermal fi-
broblasts using the Matrix-RNAi approach. We identified
PPRX1, OSR1, TWIST2 and LHX9 to be highly intercon-
nected in the fibroblastic TRN and showed that disrupt-
ing the fibroblast TRN by means of siRNA transfection al-
lowed for the induction of adipocyte-like cells in the pres-
ence of an adipogenic medium. The KD-iADP expressed
major adipocyte regulatory factors such as PPARG2 and
CEBPA endogenously, while key fibroblast-specific genes
were broadly downregulated after prolonged cultivation.
Such a transient disruption of fibroblast TRNmay be a suit-
able strategy for future reprogramming approaches.
Several approaches to enhance trans-differentiations have
been published where the authors overexpressed four iPSC
factors to partially reprogram fibroblasts into a ‘plastic’
state and induced trans-differentiation by stimulating the
cells with a cocktail of small molecule compounds designed
for various target cells (24). However, these models rely
largely on the ectopic expression of virus-mediated trans-
genes, which can integrate into the genome (25–27). In
contrary, we demonstrated that trans-differentiation could
be achieved without the need of ectopic expression of
transgenes. The chemical/cytokine cocktail of IBMX, in-
domethacin, dexamethasone and insulin was sufficient to
drive adipocyte trans-differentiation only after the disrup-
tion of the fibroblast network.
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Figure 3. Genome-wide transcriptome expression analysis of knockdown-induced adipocytes. (A) Differentially expressed Illumina microarray probes
after TRN knockdown (KD-FIB) and adipogenic induction in fibroblasts (NC-iADP) and both TRN knockdown and adipogenic induction (KD-iADP;
Benjamin–Hochberg multiple testing P-value < 0.05). (B) Induction of adipocyte-specific marker genes in KD-FIB, NC-iADP and KD-iADP. Each gene
was independently validated by qRT-PCR. (C) Gene ontology analysis reveals increase in gene expression involved in adipocyte functions such as lipid,
fatty acid and steroid metabolic processes in KD-iADP 2 weeks post transfection.
The siRNA transfection is an ideal strategy for cell re-
programming due to their transient properties in the host
cell (28,29). Interestingly, our data suggest that a pro-
longed cultivation of siRNA transfection (3 weeks) can
maintain adipocyte-specific expression and phenotype. This
suggests that the temporary suppression of the fibroblast
TRN was sufficient to allow fibroblasts to overcome the
cellular barrier and transit into a new state. However, be-
cause adipocytes and fibroblasts share the same mesenchy-
mal lineage, a more stable suppression of the fibroblast
TRN may promote efficient trans-differentiation into non-
mesenchymal lineages.
Interestingly, we observed that the adipogenic-induction
cocktail alone failed to induce PPARG2 expression, thus
no lipid accumulation in putative fibroblast cells. PPARG2
plays a pivotal role in adipocyte differentiation and trans-
differentiation (30). Ectopic expression of PPARG2 in con-
junction with CEBPA was reported to induce a significant
transformation into adipocyte-like cells in mouse embry-
onic fibroblasts (31–33). More recently, we observed that
PPARG2 overexpression in human dermal fibroblasts in-
duced far less adipocytes than inMSCs (11). Moreover, sta-
ble expression of fibroblastic TRN led to an inhibition of
adipogenesis (Supplementary Figure S2). Collectively, this
study demonstrates that the fibroblast TRN is more robust
(i.e. resistant to change) than the MSC TRN, suggesting
the existence of safeguard mechanisms in fully differenti-
ated somatic cells to prevent aberrant trans-differentiations.
Strikingly, the combination of both disruption of the fi-
broblast TRN and the chemical-based adipogenic induc-
tion led to endogenous activations of several key drivers of
adipocyte network, namely PPARG2 and CEBPA (Figure
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Figure 4. Comparison of KD-iADP cells with adipocytes. (A) Principal component analysis (PCA) of MSC-differentiation time course (orange), pre-
adipocytes tomature adipocytes differentiation (dark red) and perturbed fibroblasts (blue) reveal thatKD-iADPalignwith the pre-adipocyte differentiation
pathway. Each circle represents a single microarray experiment and each condition is profiled in triplicates. (B) Quantification of upregulated genes in
KD-iADP reveals significant induction of genes that are highly specific in mature adipocytes. (C) Conversely, large numbers of fibroblast genes were
downregulated in NC-iADP and KD-iADP. The combination of knockdown and induction leads to a greater suppression of fibroblast genes.
3B). It is possible that disrupting the fibroblastic TRN may
broadly modify the epigenetic landscape of fibroblast cells,
exposing the promoter regions of key adipocyte promot-
ers, such as PPARG, for transcriptional activation (34), and
only in combination with induction medium where com-
pounds such as dexamethasone can induce wide range of
epigenetic modifications and activate gene expression and
differentiation (35). Thus, a synergistic role of the network
disruption and the addition of chemical agents may be es-
sential to induce transgene-free cell reprogramming.
We present the fibroblast-enriched TF set from the largest
expression dataset (FANTOM5) and present the fibrob-
lastic TRN model built by Matrix-RNAi. Moreover, we
showed the first evidence that specifically targeting the TRN
of fibroblasts promotes adipogenic trans-differentiation in
the presence of a defined chemical cocktail without the need
of ectopic expression. Therefore, targeting the gene regula-
tory network provides a novel strategy to induce or enhance
cellular reprogramming pathways.
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